Answers are grounded in this paper and cite their sources.
We investigated the long-term efficacy and safety of intrasphincteric injections of botulinum toxin (100 U) in 57 patients with esophageal achalasia. One month after treatment, 50 patients had improved (88%); both symptom score and LES pressure were significantly reduced (P < 0.001). After a mean follow-up of 24+/-15 months (range 6-48), 43 patients (75%) are still in remission, although repeat injections of toxin were needed to achieve a stable effect on symptoms.
No takes yet. Share an insight, caveat, or question.
Annese et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: